CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage

The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.

from Health and Science https://ift.tt/3mR0XzY
https://ift.tt/D6IVbW3
https://ift.tt/fld7uQK